Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Validation01:15

Data Validation

3.3K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
3.3K
Data Validation01:03

Data Validation

7.1K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
7.1K
Case Studies01:22

Case Studies

13.8K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
13.8K
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

5.6K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
5.6K
Development of Analytical Methods01:21

Development of Analytical Methods

2.8K
An analytical methodology can be divided into four sequential steps: technique, method, procedure, and protocol. A technique is a scientific principle that rationalizes a specific phenomenon through chemical measurements. Adapting a technique for analyzing a sample of interest is termed a method. The procedure outlines the directions for performing the analysis via an analytical method. The protocol is the detailed guidelines on the procedure, which should be strictly followed to obtain the...
2.8K
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

11.2K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome.

American journal of hematology·2026
Same author

Integrating Clinical, Functional, and Patient-Reported Outcomes in Haemophilia Care: A Delphi-Based Consensus on a New Monitoring Tool.

Journal of clinical medicine·2026
Same author

IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation.

International journal of molecular sciences·2026
Same author

Updated global prevalence and ethnic diversity of von Willebrand disease based on population genetics analysis.

Scientific reports·2026
Same author

Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working Group.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same journal

Male Range of Motion Norms in the Haemophilia Joint Health Score Underrepresent the Severity of Joint Damage in Females.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Physical Activity and Sedentary Behaviour in Children With Haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Ten-year Demographic and Clinical Characterisation of People With Haemophilia: The Colombian Registry Experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Enactive Phenomenological Approach to the Trier Social Stress Test: A Mixed Methods Point of View
05:26

Enactive Phenomenological Approach to the Trier Social Stress Test: A Mixed Methods Point of View

Published on: January 7, 2019

7.3K

SIPPET: methodology, analysis and generalizability.

F Peyvandi1,2, P M Mannucci1,2, R Palla1

  • 1Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Luigi Villa Foundation, Milan, Italy.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|March 18, 2017
PubMed
Summary
This summary is machine-generated.

Recombinant FVIII (rFVIII) led to an 87% higher rate of inhibitor development compared to plasma-derived FVIII (pdFVIII) in previously untreated patients with severe hemophilia A during the first 50 exposure days.

Keywords:
factor VIIIhaemophiliainhibitorsplasma productsrecombinant products

More Related Videos

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

Related Experiment Videos

Last Updated: Mar 6, 2026

Enactive Phenomenological Approach to the Trier Social Stress Test: A Mixed Methods Point of View
05:26

Enactive Phenomenological Approach to the Trier Social Stress Test: A Mixed Methods Point of View

Published on: January 7, 2019

7.3K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

Area of Science:

  • Hematology
  • Immunology
  • Pharmacology

Background:

  • Development of neutralizing alloantibodies (inhibitors) against Factor VIII (FVIII) affects one-third of previously untreated patients (PUPs) with severe hemophilia A.
  • Previous studies on FVIII concentrate immunogenicity yielded inconclusive results due to variations in study design and methodology.
  • The SIPPET trial was initiated to address the unresolved question of inhibitor development risk associated with different FVIII concentrates.

Purpose of the Study:

  • To compare the inhibitor development rates between plasma-derived FVIII (pdFVIII) and recombinant FVIII (rFVIII) in previously untreated or minimally treated patients with severe hemophilia A.
  • To provide answers to key questions arising from the SIPPET trial's findings.

Main Methods:

  • The SIPPET trial was a randomized trial involving 251 previously untreated or minimally treated patients with severe hemophilia A.
  • Patients were treated with either a single plasma-derived FVIII (pdFVIII) concentrate containing VWF or a recombinant FVIII (rFVIII) concentrate.
  • Inhibitor development was monitored during the initial 50 exposure days.

Main Results:

  • The study found an 87% higher rate of inhibitor development in patients treated with rFVIII compared to those treated with pdFVIII.
  • This difference was observed during the first 50 exposure days of treatment.

Conclusions:

  • Treatment with recombinant FVIII (rFVIII) is associated with a significantly higher risk of inhibitor development compared to plasma-derived FVIII (pdFVIII) in severe hemophilia A.
  • These findings have implications for treatment decisions and regulatory considerations regarding FVIII concentrates.